Viewing Study NCT04752358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-02 @ 1:21 PM
Study NCT ID: NCT04752358
Status: TERMINATED
Last Update Posted: 2024-09-04
First Post: 2021-02-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)
Sponsor: Adaptimmune
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Esophagogastric Junction Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cell Therapy View
None T Cell Therapy View
None SPEAR T Cell View
None MAGE-A4 View
None Immuno-oncology View
None Metastatic View
None Esophagogastric Junction View
None Esophageal Cancer View